Laboratory (Bar Harbor, ME). The IRF1-KO mice were crossed with C57BL/6J mice to produce the F1 generation (IRF1 heterozygotes), which was backcrossed with the C57BL/6J strain to obtain the F2 generation (IRF1 heterozygotes) and then further backcrossed to the C57BL/6J background until the F9 generation (IRF1 heterozygotes). Male and female mice of the F9 generation were crossed with each other to produce IRF1-KO mice in a pure C57BL/6J background. Male α-MHC-IRF1 (TG) mice and their non-transgenic (NTG) littermates as well as IRF1-KO mice and their wild-type (WT) littermates (aged 8 to 10 weeks with body weights of 24-27 g) were used in these experiments. The iNOS-knockout mice (B6.129P2-NOS2 tm1Lau /J; Stock No. 002609) were purchased from the Jackson Laboratory; iNOS knockout mice with pure C57BL/6J background were obtained by using the similar method as IRF1 knockout mice (C57BL/6J background). IRF1-TG mice were crossed with iNOS-KO mice to produce IRF1-TG/iNOS-KO mice in a C57BL/6J background. All of the animals were housed in an environment with controlled light cycles (12 hours light/12 hours dark), temperature, and humidity; food and water were available ad libitum. All of the animal experiments were performed by an experimenter who was blinded to the animals' genotypes.
Creation of an IRF1-Knockout Rat Model
Transcription activator-like effector (TALE) DNA binding domains were designed using an earlier version of targeter designer (https://tale-nt.cac.cornell.edu/node /add/talen-old). TALE repeats were assembled using the "Unit Assembly" method, 3 and were then used to construct a modified transcription activator-like effector nuclease (TALEN) expression vector with a T7 promoter for in vitro RNA production. The TALEN expression plasmids were linearized with PmeI (NEB, R0560L) and purified with phenol/chloroform to generate an RNase-free DNA template for in vitro transcription. Mature mRNA was transcribed from the above-mentioned templates using the mMessage mMachine T7 Ultra Kit (Ambion, AM1345), and it was purified using the RNeasy Mini Kit (Qiagen, 74104) following the manufacturer's instructions. Each TALEN mRNA was diluted to 10 ng/µl with an injection buffer (10 mM Tris-HCl/0.1 mM EDTA, pH 7.4). A 2 pl aliquot of the solution was injected into cytoplasm of one cell stage embryos using the FemtoJet 5247 microinjection system under standard conditions. The surviving embryos were transferred to surrogate mothers. For F0 offspring genotyping, a 670 bp DNA fragment overlapping the TALEN target site was amplified by PCR with the primers IRF1-FWD (5'-ATAAACAAGC AGCCAACACCTGC-3') and IRF1-REV (5'-GTCAAGGACCTTTAGTTAGGACC-3') using an annealing temperature of 63°C. The completed PCRs were divided into two equal aliquots. The first aliquot was used as a template for sequencing to allow the identification of editing events. The other aliquot was purified and TA cloned following the manufacturer's instructions (TaKaRa). Eight bacterial colonies per sample were chosen, amplified using M13-47/Rv-M primers, and sequenced. To genotype the F1 and F2 offspring, PCR products from F1 and F2 offspring were genotyped using the DNA restriction enzyme SphI (TaKaRa, 1246A).
Aortic Banding Surgery
Aortic banding (AB) was performed as described previously. [4] [5] [6] Briefly, after anesthetization with sodium pentobarbital (50 mg/kg, Sigma) via an intraperitoneal injection, the left chest of each mice was opened to identify the thoracic aorta by blunting dissection at the second intercostal space. We then performed AB by tying a 7-0 silk suture around a specific needle on the thoracic aorta. After ligation, the 27-gauge needle was quickly removed, and adequate constriction of the aorta was confirmed by Doppler analysis. Sham-operated mice underwent the same surgical procedure without constriction of the aorta.
To produce pressure-overloaded cardiac hypertrophy in rats which were 40 days old and weighed 200-250 g, and aortic banding was performed by constricting the abdominal aorta at the suprarenal level as described in published method. 7 Briefly, rats were anesthetized, the abdominal aorta was exposed under sterile conditions through a midline abdominal incision. The abdominal aortas were banded against a 29-gauge needle that was removed before closing the abdominal cavity with a 7-0 silk suture. In addition, Doppler analysis was used to verify adequate constriction of the aortas. Sham-operated rats had an untied ligature placed in the same location.
Echocardiography and Hemodynamic Evaluation
Echocardiography and hemodynamic measurements was performed essentially as described previously. 8, 9 Briefly, echocardiography was performed with a MyLab 30CV ultrasound system (Biosound Esaote Inc.) equipped with a 15-MHz transducer. End-systole and end-diastole were defined as the phase in which the smallest or largest LV area was obtained, respectively. The LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), and LV wall thickness were measured from the LV M-mode tracing with a sweep speed of 50 mm/s at the mid-papillary muscle level.
For the hemodynamic analysis, a 1.4-F Millar micro-tip catheter (SPR-839; Millar Instruments, Houston, Texas) was inserted into the right carotid artery and advanced into the left ventricle. After stabilization for 15 minutes, the heart rate, pressure, and volume signals were recorded continuously using a pressure-volume conductance system (MPVS-300 Signal Conditioner, Millar Instruments, Inc.). The results were analyzed with Chart 5.0 software.
Histological Analysis
Hearts were excised, arrested in diastole with a 10% potassium chloride solution, fixed with 10% formalin, then dehydrated, and embedded in paraffin. Subsequently, the hearts were sectioned transversely close to the apex to visualize the left and right ventricles at 5 µm. The sections were stained with hematoxylin and eosin (HE) for histopathology or with picrosirius red (PSR) to identify collagen deposition and were subsequently visualized by light microscopy. To determine the myocyte cross-sectional area, sections were stained with FITC-conjugated wheat germ agglutinin (WGA, Invitrogen Corp) to visualize the membranes and with DAPI to observe the nuclei. More than 100 LV myocytes were examined in each group. Single myocytes and fibrillar collagen were visualized by microscopy and were measured using a quantitative digital image analysis system (Image-Pro Plus 6.0).
Cardiomyocyte Culture and Infection with Recombinant Adenoviral Vectors
Primary neonatal rat cardiomyocytes (NRCMs) were prepared from the hearts of 1-to 2-day-old SD rat pups as previously described. 8, 10 To overexpress IRF1, the entire coding region of the rat IRF1 gene was subcloned into the pShuttle-cytomegalovirus (CMV) vector using the AdEasy XL Adenoviral Vector System (Stratagene). A similar adenoviral vector encoding the GFP gene was used as a control. To knock down IRF1 expression, we transfected cells with rat shIRF1 constructs (SABiosciences, KR06456G) or the AdshRNA negative control at a multiplicity of infection (MOI) of 100. After adenoviral infection, the cells were grown in DMEM/F12 medium containing 20% FCS, BrdU (0.1 mM, to inhibit fibroblast proliferation), and penicillin/streptomycin without serum for 24 hours, followed by treatment with angiotensin II (Ang II, 1 µmol/L) or PBS for an additional 48 hours. For surface area measurements, the cells were stained with a-actinin (Sigma) and were quantitatively analyzed using the Image-Pro Plus software (version 6.0).
Quantitative Real-Time PCR and Western Blotting
Quantitative real-time PCR and western blotting were performed as previously described. 2, 8 Briefly, after total RNA was extracted from ventricles and primary cells using TRIzol reagent (Invitrogen), first strand cDNA was synthesized using a Transcriptor First Strand cDNA Synthesis Kit (Roche, 04896866001). Quantitative real-time PCR was performed using the SYBR Green PCR Master Mix (Roche, 04887352001) to determine the expression levels of our genes of interest, and the results were normalized against GAPDH gene expression. The real-time PCR primers that were used are shown in Supplementary Table S1 . For western blotting, cardiac tissue and cultured cardiac myocytes were lysed in RIPA lysis buffer. Protein extracts (30 µg) were separated by SDS-PAGE, transferred to polyvinylidene difluoride (PVDF) membranes, and probed with various primary antibodies. After incubation with secondary antibodies for 1 hour at room temperature, the membranes were treated with ECL reagents (170-5061, Bio-Rad) prior to visualization using a FluorChem E imager (ProteinSimple, FluorChem E) according to the manufacturer's instructions. The specific protein expression levels were normalized to the levels of GAPDH on the same PVDF membrane.
Luciferase Reporter Assays
The iNOS promoter luciferase (iNOS-luc) plasmid was obtained from Addgene (cat no. 19296), subcloned into the pGL3-basic vector (Promega) and subsequently transferred into by replication-defective adenoviral vectors. Primary neonatal rat cardiomyocytes (NRCMs) cultured in 24-well plates were co-infected with the AdiNOS-luc and AdIRF1 (AdGFP as the control) or AdshIRF1 (AdshRNA as the control) recombinant adenoviruses. After being stimulated with Ang II for 24 hours, the cells were harvested and lysed with 100 µl of passive lysis buffer (PLB, Promega). The cell debris was removed by centrifugation, and the supernatant was used for luciferase assays which were performed using a single-mode SpectraMax® microplate reader according to the manufacturer's instructions.
Chromatin Immunoprecipitation Assays
In brief, after being transfected with HA-tagged IRF1 or the pcDNA3.1 control for 48 hours, cultured NIH3T3 cells were fixed with 1% formaldehyde for 10 minutes. The cross-linking reacting was halted by adding 1 ml of ice-cold glycine at room temperature, and the cells were washed, harvested, and sonicated on ice. After preclearing with protein G/A beads, the soluble chromatin was immunoprecipitated using an anti-HA antibody (ab9110, Abcam) or rabbit IgG (2729S, Cell Signaling Technology, Beverly, MA, USA) as a control at 4°C overnight with rotation. The chromatin was then eluted from the beads and reverse cross-linked overnight, and the precipitated DNA was purified using phenol/chloroform extraction. Quantitative real-time PCR was performed for 40 cycles to detect putative IRF1-binding regions (P1-P5). The PCR primers for the ChIP assays are listed in Supplementary Table S2 .
Statistical Analysis
The data are presented as the mean ± SD. Differences among groups were assessed using an analysis of variance followed by a post hoc Tukey's test. Comparisons between two groups were performed using Student's t-test. A value of P<0.05 was considered to indicate a statistically significant difference.
Supplementary Tables
Supplementary Table S1 . The primers for Real-Time PCR. 
Primer name Forward Primer Reverse Primer

Primer name Primer
M=mouse; F= forward; R=reverse
Supplementary Table S3 . Sequencing results of IRF1 mutant allele in 6 founder rats, revealing different indel mutations in the TALEN target site. The mutation region of founders IRF1 gene was PCR-amplified then sub-cloned into TA vector. SphI site is underlined. N indicates the base.
Lines Allele Sequence Indel (bp)
Wild Type AGATCCCATGGAAGCATGCTGCCAAGCACGGTTGGGACATCAACAAGGATG 0
F 2-1(allele 1) AGATCCCATGGAAGC--------AAGCACGGTTGGGACATCAACAAGGATG △8
F2-1(allele 2) AGATCCCATGGAAGC-----------CACGGTTGGGACATCAACAAGGATG △12
F 2-2(allele 1) AGATCCCATGGAAGCA-------AAGCACGGTTGGGACATCAACAAGGATG △7
F 2-2(allele 2) AGATCCCATGGAAGC------------ACGGTTGGGACATCAACAAGGATG △12
F 2-3 AGATCCCATGGAAGC------------ACGGTTGGGACATCAACAAGGATG △12
Wild Type AGATCCCATGGAAGC(NNNNNNNNNNN)AAGGTCCTAACTAAAGGTCCTTGA 0
F=founder Supplementary Table S4 . Germline transmission of the IRF1 knockout founders. Three of the 6 founders were bred to wild type rats to measure germline transmission. The number of F1 pup with wild type and mutant alleles is shown over total number pup for each founder. Specific modifications of the alleles are shown in above ( Table  2) . 
